HYPOURICAEMIA AND IN APPROPRIAT SECRETION OF ANTIDIURETIC HORMONE IN SMALL CELL BRONCHOGENIC CARCINOMAOSTERLIND K; HANSEN M; DOMBERNOWSKY P et al.1981; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1981; VOL. 209; NO 4; PP. 289-291; BIBL. 7 REF.Article

Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiationØSTERLIND, K; ANDERSEN, P. K.Cancer research (Baltimore). 1986, Vol 46, Num 8, pp 4189-4194, issn 0008-5472Article

PHASE II STUDY OF VINBLASTINE IN SMALL CELL CARCINOMA OF THE LUNG = ETUDE PHASE II DE LA VINBLASTINE DANS LES EPITHELIOMAS BRONCHIQUES A PETITES CELLULESSORENSON S; OSTERLIND K; DOMBERNOWSKY P et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 3; PP. 293-295; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

VINDESINE IN THE TREATMENT OF SQUAMOUS CELL CARCINOMA ADENOCARCINOMA, AND LARGE CELL CARCINOMA OF THE LUNGOSTERLIND K; HORBOV S; DOMBERNOWSKY P et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 305-309; BIBL. 17 REF.Article

VINDESINE IN THE TREATMENT OF SMALL CELL ANAPLASTIC BRONCHOGENIC CARCINOMAOSTERLIND K; DOMBERNOWSKY P; SORENSEN PG et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 245-248; BIBL. 11 REF.Article

COMBINATION CHEMOTHERAPY WITH CCNU, MELPHALAN, METHOTREXATE, AND PREDNISONE (CAMP) IN 35 PATIENTS WITH ADVANCED BREAST CANCER.HANSEN M; PALSHOF T; OSTERLIND K et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 8; PP. 1603-1605; BIBL. 6 REF.Article

The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health organization = La signification pronostique de la sous-classification histologique des épithiliomas à petites cellules du poumon en fonction de la classification de l'organisation mondiale de la santé. Une étude de 375 cas consécutifsHIRSCH, F. R; ØSTERLIND, K; HANSEN, H. H et al.Cancer. 1983, Vol 52, Num 11, pp 2144-2150, issn 0008-543XArticle

Detection of bone marrow relapse in patients with small cell carcinoma of the lungKRISTJANSEN, P. E. G; ØSTERLIND, K; HANSEN, M et al.Cancer. 1986, Vol 58, Num 11, pp 2538-2541, issn 0008-543XArticle

Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancerØSTERLIND, K; HØI HANSEN, H; DOMBERNOWSKY, P et al.Cancer research (Baltimore). 1987, Vol 47, Num 10, pp 2733-2736, issn 0008-5472Article

Vinca alkaloids in the treatment of non small cell lung cancerSORENSEN, J. B; OSTERLIND, K; HANSEN, H. H et al.Cancer treatment reviews. 1987, Vol 14, Num 1, pp 29-51, issn 0305-7372Article

Cyclic alternating «non-cross resistant» chemotherapy in the management of small cell anaplastic carcinoma of the lungELLIOTT, J. A; OSTERLIND, K; HANSEN, H. H et al.Cancer treatment reviews. 1984, Vol 11, Num 2, pp 103-113, issn 0305-7372Article

Lung abscess in small cell carcinoma of the lung during chemotherapy and corticosteroids: an analysis of 276 consecutive patientsHANSEN, S. W; AABO, K; OSTERLIND, K et al.European journal of respiratory diseases. 1986, Vol 68, Num 1, pp 7-11, issn 0106-4339Article

Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008DALTON, S. O; FREDERIKSEN, B. L; JACOBSEN, E et al.British journal of cancer. 2011, Vol 105, Num 7, pp 1042-1048, issn 0007-0920, 7 p.Article

A meta-analysis of thoracic radiotherapy for small-cell lung cancerPIGNON, J.-P; ARRIAGADA, R; ONOSHI, T et al.The New England journal of medicine. 1992, Vol 327, Num 23, pp 1618-1624, issn 0028-4793Article

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma : A prospective randomised trial of 280 consecutive patientsHIRSCH, F. R; ØSTERLIND, K; JEPPESEN, N et al.Annals of oncology. 2001, Vol 12, Num 5, pp 647-653, issn 0923-7534Article

Epidemiological and clinical aspects of carcinoma in situ of the testis. DiscussionGIWERCMAN, A; VON DER MAASE, H; FAIR, W. R et al.VON DER MAASE, H; GIWERCMAN, A; European urology. 1993, Vol 23, Num 1, pp 104-114, issn 0302-2838Conference Paper

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-upØSTERLIND, K; HANSEN, H. H; HANSEN, H. S et al.British journal of cancer. 1986, Vol 54, Num 1, pp 7-17, issn 0007-0920Article

Chromogranin A, a significant prognostic factor in small cell lung cancerDRIVSHOLM, L; PALOHEIMO, L. I; ØSTERLIND, K et al.British journal of cancer. 1999, Vol 81, Num 4, pp 667-671, issn 0007-0920Conference Paper

Urokinase and plasminogen activator inhibitor 1 in pulmonary adenocarcinomaPEDERSEN, H; GRØDAHL-HANSEN, J; FRANCIS, D et al.Cancer research (Baltimore). 1994, Vol 54, Num 1, pp 120-123, issn 0008-5472Article

Syndrome of inappropriate antidiuresis in small-cell lung cancer: classification and effect of tumor regressionSØRENSEN, J. B; KRISTJANSEN, P. E. G; ØSTERLIND, K et al.Acta medica Scandinavica. 1987, Vol 222, Num 2, pp 155-161, issn 0001-6101Article

Controlled trial of RSV, herbs or placebo as adjuvants to complete resection of squamous cell lung cancerØSTERLIND, K; HANSEN, M; HANSEN, H. H et al.European journal of surgical oncology. 1985, Vol 11, Num 4, pp 349-351, issn 0748-7983Article

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapyRYBERG, M; NIELSEN, D; ØSTERLIND, K et al.Annals of oncology. 2001, Vol 12, Num 1, pp 81-87, issn 0923-7534Article

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancerBOISEN, M. K; JOHANSEN, J. S; KELDSEN, N et al.Annals of oncology. 2013, Vol 24, Num 10, pp 2554-2559, issn 0923-7534, 6 p.Article

Outcome of combination chemotherapy in extensive stage small-cell lung cancer : Any treatment related progress ?LASSEN, U. N; HIRSCH, F. R; ØSTERLIND, K et al.Lung cancer. 1998, Vol 20, Num 3, pp 151-160, issn 0169-5002Article

Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC)JØRGENSEN, L. G. M; ØSTERLIND, K; HANSEN, H. H et al.British journal of cancer. 1992, Vol 66, Num 3, pp 594-598, issn 0007-0920Article